Development and Characterization of Transferrin-Conjugated Polymeric Nanoparticles for Brain-Targeted Delivery in Parkinson’s Diseas

1. Introduction 1.1 Background and Significance 1.2 Objectives of the Study 1.3 Scope and Limitations 1.4 Structure of the Thesis 2. Parkinson’s Disease Overview 2.1 Pathophysiology of Parkinson’s Disease 2.2 Current Treatment Strategies 2.3 Challenges in Drug Delivery 3. Nanoparticle Drug Delivery Systems 3.1 Types of Polymeric Nanoparticles 3.2 Mechanism of Drug Delivery 3.3 Advantages of Nanoparticles in Medicine 4. Transferrin-Conjugated Nanoparticles 4.1 Role of Transferrin in Drug Targeting 4.2 Conjugation Techniques 4.3 Previous Studies and Findings 5. Development of the Nanoparticles 5.1 Materials and Methods 5.2 Synthesis of Nanoparticles 5.3 Characterization Techniques 6. Characterization Results 6.1 Size and Morphology Analysis 6.2 Surface Charge Measurement 6.3 Drug Loading Efficiency 7. Evaluation of Brain-Targeted Delivery 7.1 In Vitro Studies 7.2 In Vivo Animal Models 7.3 Efficacy and Safety Analysis 8. Conclusion and Future Directions 8.1 Summary of Findings 8.2 Limitations of Current Study 8.3 Potential for Future Research